Israeli vaccine evolves to mimic Omicron
NRx Pharmaceuticals (Nasdaq: NRXP), which is developing the BriLife coronavirus vaccine of the Israel Institute for Biological Research (IIBR), under license from the Ministry of Defense, reports that it has…